ADVANCED STRATEGIES

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$2.0M

Filings

Unique Clients

Active Period

1999–2014

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2014	$150,000	4	1
2013	$350,000	4	1
2012	$280,000	4	1
2011	$310,000	4	1
2010	$380,000	4	1
2009	$300,000	6	1
2004	$10,000	4	2
2003	$80,000	2	2
2002	$40,000	2	2
2001	$120,000	6	2
2000	—	2	1
1999	—	2	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
COVIDIEN INC	$1,770,000	26	2009–2014
JOHN HANCOCK FINANCIAL SERVICES	$140,000	9	2001–2004
STATE STREET BANK & TRUST	$110,000	9	1999–2004

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	29
SENATE	29
Executive Office of the President (EOP)	1

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	23
Health Issues	Health Issues	15
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	8
Energy/Nuclear	Energy/Nuclear	7
Insurance	Insurance	3
Retirement	Retirement	2
Environment/Superfund	Environment/Superfund	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 523113th Congress

Protect Medical Innovation Act of 2013

2014 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical innovation

Client expense: — · Firm income: $70,000

Matched citations: H.R. 523

S. 232113th Congress

Medical Device Access and Innovation Protection Act

2014 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical innovation

Client expense: — · Firm income: $70,000

Matched citations: S. 232

H.R. 523113th Congress

Protect Medical Innovation Act of 2013

2013 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical Innovation International Tax Issues

Client expense: — · Firm income: $80,000

Matched citations: H.R. 523

S. 232113th Congress

Medical Device Access and Innovation Protection Act

2013 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical Innovation International Tax Issues

Client expense: — · Firm income: $80,000

Matched citations: S. 232

Show 21 more cited filings

H.R. 523113th Congress

Protect Medical Innovation Act of 2013

2013 · third_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical Innovation International Tax issues

Client expense: — · Firm income: $80,000

Matched citations: H.R. 523

S. 232113th Congress

Medical Device Access and Innovation Protection Act

2013 · third_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and Innovation Protection Act H.R. 523 Protection of Medical Innovation International Tax issues

Client expense: — · Firm income: $80,000

Matched citations: S. 232

H.R. 523113th Congress

Protect Medical Innovation Act of 2013

2013 · second_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access & Innovation Protection Act H.R. 523 Protection of Medical innovation International Tax Issues

Client expense: — · Firm income: $110,000

Matched citations: H.R. 523

S. 232113th Congress

Medical Device Access and Innovation Protection Act

2013 · second_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access & Innovation Protection Act H.R. 523 Protection of Medical innovation International Tax Issues

Client expense: — · Firm income: $110,000

Matched citations: S. 232

H.R. 523113th Congress

Protect Medical Innovation Act of 2013

2013 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and innovation Protection Act HR 523 Protect Medical Innovation

Client expense: — · Firm income: $80,000

Matched citations: HR 523

H.R. 523113th Congress

Protect Medical Innovation Act of 2013

2013 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and innovation Protection Act HR 523 Protect Medical innovation

Client expense: — · Firm income: $80,000

Matched citations: HR 523

S. 232113th Congress

Medical Device Access and Innovation Protection Act

2013 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and innovation Protection Act HR 523 Protect Medical Innovation

Client expense: — · Firm income: $80,000

Matched citations: S. 232

S. 232113th Congress

Medical Device Access and Innovation Protection Act

2013 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

S. 232 Medical Device Access and innovation Protection Act HR 523 Protect Medical innovation

Client expense: — · Firm income: $80,000

Matched citations: S. 232

H.R. 3276111th Congress

American Medical Isotopes Production Act of 2010

2010 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3276 - American Medical Isotopes Production Act of 2009

Client expense: — · Firm income: $90,000

Matched citations: HR 3276

H.R. 3276111th Congress

American Medical Isotopes Production Act of 2010

2010 · third_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3276 - American Medical Isotopes production Act of 2009

Client expense: — · Firm income: $90,000

Matched citations: HR 3276

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · second_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

Health Care Reform: HR 3590 Patient Protection and Affordable Care Act - issues relating to medical device tax

Client expense: — · Firm income: $110,000

Matched citations: HR 3590

H.R. 3276111th Congress

American Medical Isotopes Production Act of 2010

2010 · second_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3276 - American Medical Isotopes Production Act of 2009

Client expense: — · Firm income: $110,000

Matched citations: HR 3276

H.R. 3962110th Congress

Superfund Polluter Pays Act

2010 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 4872 - The Healthcare and education Affordability Reconciliation Act of 2010 HR 3590 - Patient Protection and Affordable Care Act of 2009 HR 3962 - Affordable Healthcare for Americans Act Issues related to the medical device tax/fee

Client expense: — · Firm income: $90,000

Matched citations: HR 3962

H.R. 3276111th Congress

American Medical Isotopes Production Act of 2010

2010 · first_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3276 - American Medical isotopes Production Act of 2009 HEU/LEU related issues for nuclear medicine

Client expense: — · Firm income: $90,000

Matched citations: HR 3276

H.R. 3962110th Congress

Superfund Polluter Pays Act

2009 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act of 2009 (HR 3590) "Affordable Health Care for America Act" (HR 3962) s. 1796 "The Americas Healthy Future Act of 2009" Issues relating to the medical device tax

Client expense: — · Firm income: $120,000

Matched citations: HR 3962

H.R. 4173110th Congress

Overseas Voting Education and Reform, Safeguarding Every American's Vote Act

2009 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

Financial Regulatory Reform - Issues relating to derivatives Wall Street Reform and Consumer Protection Act (HR 4173)

Client expense: — · Firm income: $120,000

Matched citations: HR 4173

H.R. 3276111th Congress

American Medical Isotopes Production Act of 2010

2009 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3276 American medical Isotopes Production Act of 2009 ENG Related issues for nuclear medicine

Client expense: — · Firm income: $120,000

Matched citations: HR 3276

S. 1796111th Congress

America's Healthy Future Act of 2009

2009 · fourth_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

Patient Protection and Affordable Care Act of 2009 (HR 3590) "Affordable Health Care for America Act" (HR 3962) s. 1796 "The Americas Healthy Future Act of 2009" Issues relating to the medical device tax

Client expense: — · Firm income: $120,000

Matched citations: s. 1796

H.R. 3200111th Congress

America's Affordable Health Choices Act of 2009

2009 · third_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3200, America's Affordable Health Choice Act of 2009 Senate Finance Committee Healthcare Reform Proposal S. 1679 Affordable Health Choices Act (HELP Bill)

Client expense: — · Firm income: $70,000

Matched citations: HR 3200

H.R. 3276111th Congress

American Medical Isotopes Production Act of 2010

2009 · third_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3276 American Medical Isotopes Production Act

Client expense: — · Firm income: $70,000

Matched citations: H.R. 3276

S. 1679111th Congress

Affordable Health Choices Act

2009 · third_quarter · Client: COVIDIEN INC

Open original LDA filing ↗

Cited source text and reported amounts

HR 3200, America's Affordable Health Choice Act of 2009 Senate Finance Committee Healthcare Reform Proposal S. 1679 Affordable Health Choices Act (HELP Bill)

Client expense: — · Firm income: $70,000

Matched citations: S. 1679

Source: Senate LDA

ADVANCED STRATEGIES — Lobbying Disclosure | Poliscope